Skip to main content Skip to main navigation menu Skip to site footer
Review
Published: 03-06-2022

Licopeno e prevenção do câncer de próstata: Uma revisão integrativa

Departamento de Nutrição e Farmácia, UNINTA Centro Universitário, Sobral, CE, Brasil
Departamento de Gastroenterologia, Ciências da Gastroenterologia, Universidade de São Paul
Departamento de Biotecnologia, Universidade Federal do Ceará, Ceará, CE, Brasil
Departamento de Nutrição e Farmácia, UNINTA Centro Universitário, Sobral, CE, Brasil
Departamento de Enfermagem, Universidade Estadual Vale do Acaraú, Sobral, CE, Brasil
Departamento de Nutrição e Farmácia, UNINTA Centro Universitário, Sobral, CE, Brasil
tomato neoplasias prostáticas prostate

Abstract

Currently, prostate cancer is an important public health problem, constituting one of the main types of cancer diagnosed in male patients, which is becoming the primary cause of morbidity and mortality. Studies have shown that habits and lifestyle, along with the installation of a framework of oxidative stress, are presented as important factors involved in the process of carcinogenesis. On the other hand, food habits has been considered an ally in cancer prevention through food groups with antioxidant and anti-inflammatory properties capable of acting as anticarcinogenic compounds, with lycopene being considered as a chemopreventive antioxidant. The present review summarizes some of the results relevant to the role of lycopene in the prevention of prostate cancer in the last 7 years. We have selected articles from the following databases: Scielo, Lilacs, BVS, PubMed, and MEDLINE. According to the inclusion and exclusion criteria, 20 international articles were selected. In clinical reviews, clinical trials (in vivo and in vitro) have shown the influence of the supplementation and of the consumption of lycopene from different sources of tomato-based products and other food sources in the decrease in the cell viability of prostatic cells after treatment, in addition to an increase in apoptosis and in the regulation of transcriptional levels, indicating lycopene as an important phytochemical. However, future clinical trials with the use of lycopene should be carried out to enable accurate recommendations and to provide information on the adequate consumption and amount of this compound, so that it can be used for the prevention of prostate cancer.

Metrics

Metrics Loading ...

References

  1. Perdana NR, Mochtar CA, Umbas R, Hamid AR. The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. Acta Med Indones 2016; 48 (03) 228-238
  2. BRASIL. MINISTÉRIO DA SAÚDE - Incidência de Câncer no Brasil - Instituto Nacional de Câncer: Disponível em: http://www.inca.gov.br/estimativa/2016/index.asp?ID=2 . Acesso em: 13 out. 2017.
  3. Trejo-Solís C, Jose Pedraza-Chaverrí J, Torres-Ramos M, Jiménez-Farfán D, Salgado AC, Serrano-García N, Osorio-Rico L, Julio Sotelo J. Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition. Evid Based Complement Alternat Med 2013; 21 (2013): 705121
  4. Silva CB, Moura ESB. A ação do licopeno contra o cancer. Linguagem acadêmica 2017; 7 (05) 49-56
  5. Lemos Júnior HP, Brunelli MJ, Lemos ALA. Licopeno. Diagn Tratamento 2011; 16 (02) 71-74
  6. Costa JAP, Matias AGC. Câncer de próstata e a relação quimiopreventiva do licopeno: revisão sistematizada. Revista Tempus – Actas de Saúde Coletiva 2014; 8: 223-238
  7. Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm Florianópolis 2008; 17 (04) 758-764
  8. Li D, Chen L, Zhao W, Hao J, An R. MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer. Mol Med Rep 2016; 13 (03) 2708-2714
  9. Wei MY, Giovannucci EL. Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era. J Oncol 2012; 2012: 271063
  10. Paur I, Lilleby W, Bøhn SK. , et al. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clin Nutr 2017; 36 (03) 672-679
  11. Wang Y, Jacobs EJ, Newton CC, McCullough ML. Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Int J Cancer 2016; 138 (12) 2846-2855
  12. Morgia G, Voce S, Palmieri F. , et al. Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial. Phytomedicine 2017; 34 (34) 1-5
  13. Graff RE, Judson G, Ahearn TU. , et al. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. Prostate 2017; 77 (06) 647-653
  14. Qiu X, Yuan Y, Vaishnav A, Tessel MA, Nonn L, van Breemen RB. Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev Res (Phila) 2013; 6 (05) 419-427
  15. Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas 2012; 72 (04) 269-276
  16. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev 2011; (11) CD008007
  17. Sporn MB, Liby KT, Karen T, Liby I. Is lycopene an effective agent for preventing prostate cancer?. Cancer Prev Res (Phila) 2013; 6 (05) 384-386
  18. Holzapfel NP, Holzapfel BM, Champ S, Feldthusen J, Clements J, Hutmacher DW. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci 2013; 14 (07) 14620-14646
  19. Aguilera R, Martínez ME, Winkler AA. Consumo de licopeno como reductor de incidencia en sujetos con elevado riesgo de padecer cáncer de próstata. Medwave. Santiago de Chile 2013; 13 (02) xx
  20. Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J Nutr Sci Vitaminol (Tokyo) 2013; 59 (03) 213-223
  21. Cheng P, Negi DS, Wang X. , et al. QI, M. - Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015 ;94(33)
  22. Martí R, Roselló S, Cebolla-Cornejo J. Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention. Cancers (Basel) 2016; 8 (06) 58-60
  23. Baena Ruiz R, Salinas Hernández P. Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence. Maturitas 2016; 94: 13-19
  24. Rowles III JL, Ranard KM, Smith JW, An R, Erdman Jr JW. Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 2017; 20 (04) 361-377
  25. Kristal AR, Till C, Platz EA. , et al. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2011; 20 (04) 638-646
  26. McDonald AC, Bunker CH, Raman J, Richie J, Patrick AL. Serum carotenoid and retinol levels in African-Caribbean Tobagonian men with high prostate cancer risk in comparison with African-American men. Br J Nutr 2017; 117 (08) 1128-1136
  27. Soares ND, Machado CL, Trindade BB. , et al. Lycopene Extracts from Different Tomato-Based Food Products Induce Apoptosis in Cultured Human Primary Prostate Cancer Cells and Regulate TP53, Bax and Bcl-2 Transcript Expression. Asian Pac J Cancer Prev 2017; 18 (02) 339-345

How to Cite

Bôto, E. G., Kobal, P. S., Ferreira, F. V., Lopes, L. B. M., Silva, A. S. R., & Nascimento Neto, F. das C. (2022). Licopeno e prevenção do câncer de próstata: Uma revisão integrativa. International Journal of Nutrology, 12(1), 2–12. https://doi.org/10.1055/s-0039-1693734